Catalyst Wire Dossier Catalyst Wire Dossier

Olanzapine orally disintegrating tablets 5 mg

olanzapine · Dr. Reddy's Laboratories Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Olanzapine orally disintegrating tablets 5 mg, covering 2012-01-05 to 2012-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition [Phase 1]

See pricing